Effect of Tumor Necrosis Factor on Epithelial Tight Junctions and Transepithelial Permeability

Cancer Research

Volumn 50, Issue 7, 1990, Pages 2172-2176

  Mullin, James M ^a   Snock, Kathleen V ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CACHEXIA; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SWINE; TIGHT JUNCTION;

ANIMAL; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; EPITHELIUM; IMMUNOLOGIC TECHNIQUES; IN VITRO; INTERCELLULAR JUNCTIONS; KIDNEY; PERMEABILITY; SUPPORT, U.S. GOV'T, P.H.S.; SWINE; TUMOR NECROSIS FACTOR;

EID: 0025218790     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stevenson, B. R., Anderson, J. M., and Bullivant, S. The epithelial tight junction: structure, function and preliminary characterization. Mol. Cell. Biochem., 83: 129–145, 1988.
2. Madara, J. L. Tight junction dynamics: is paracellular transport regulated? Cell, 53: 497–498, 1988.
3. Carpi–Medina, P., and Whittembury, G. Comparison of transcellular and transepithelial water osmotic permeabilities (PM) in the proximal straight tubule of the rabbit kidney. Pflugers Arch., 412: 66–74, 1988.
4. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature (Lond.), 308: 693–698, 1984.
5. Mullin, J. M., and O'Brien, T. G. Effects of tumor promoters on LLC-PK, renal epithelial tight junctions and transepithelial fluxes. Am. J. Physiol., 251: C597-C602, 1986.
6. Mullin, J. M., and McGinn, M. T. Effects of diacylglycerols on LLC–PK. renal epithelia: similarity to phorbol ester tumor promoters. J. Cell. Physiol., 134: 357–366, 1988.
7. Mullin, J. M., and McGinn, M. T. The phorbol ester, TPA, increases transepithelial epidermal growth factor flux. FEBS Lett., 221: 359–364, 1987.
8. Mullin, J. M., and Kleinzeller, A. Sugar transport in the renal epithelial cell culture. In: M. Taub (ed.), Tissue Culture of Epithelial Cells, pp. 71–85. New York: Plenum Publishing Corp., 1985.
9. Kaur, P., and Saklatvala, J. Interleukin 1 and tumor necrosis factor increase phosphorylation of fibroblast proteins. FEBS Lett., 241: 6–10, 1988.
10. Suftys, P., Van Roy, F., and Fiers, W. Tumor necrosis factor and interleukin 1 activate phospholipase in rat chondrocytes. FEBS Lett., 232: 24–28, 1988.
11. Mullin, J. M., Fluk, L., and Kleinzeller, A. Basal-lateral transport and transcellular flux of methyl a-D-glucoside across LLC-PK, renal epithelial cells. Biochim. Biophys. Acta, 885: 233–239, 1986.
12. Mullin, J. M., and McGinn, M. T. Epidermal growth factor-induced mito-genesis in kidney epithelial cells (LLC–PK,). Cancer Res., 48: 4886–4891, 1988.
13. Smith, R. A., and Baglioni, C. The active form of tumor necrosis factor is a trimer. J. Biol. Chem., 262: 6951–6954, 1987.
14. Mandel, L. J. Primary active sodium transport, oxygen consumption, and ATP: coupling and regulation. Kidney Int., 29: 3–9, 1986.
15. Gullans, S. R., Harris, S. I., and Mandel, L. J. Glucose–dependent respiration in suspensions of rabbit cortical tubules. J. Membr. Biol., 78: 257–262, 1984.
16. Beutler, B., and Cerami, A. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med., 316: 379–385, 1987.
17. Scuderi, P., Lam, K. S., Ryan, K. J., Petersen, E., Sterling, K. E., Finley, P. R., Ray, C. C., Slymen, D. J., and Salmon, S. E. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet, 2: 1364–1365, 1986.
18. Socher, S. H., Martinez, D., Craig, J. B., Kuhn, J. G., and Oliff, A. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J. Natl. Cancer Inst., 80: 595–598, 1988.
19. Owen-Schaub, L. B., Gutterman, J. U., and Grimm, E. A. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor a and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res., 48: 788–792, 1988.
20. Howells, G. L., Chantry, D., and Feldmann, M. Interleukin 1 (IL-1) and tumor necrosis factor synergize in the induction of IL-1 synthesis by human vascular endothelial cells. Immunol. Lett., 19: 169–173, 1988.
21. Warner, S. J. C., and Libby, P. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J. Immunol., 142: 100–109, 1989.
22. Tredget, E. E., Yu, Y. M., Zhong, S., Burini, R., Okusawa, S., Gelfano, J. A., Dinarello, C. A., Young, V. R., and Burke, J. F. Role of interleukin 1 and tumor necrosis factor on energy metabolism in rabbits. Am. J. Physiol., 255: E760-E768, 1988.
23. Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., and Fiers, W. Evidence for tumor necrosis factor/cachectin production in cancer. Lancet, 2: 1229–1232, 1987.
24. Lahdevirta, J., Maury, C.P.J., Teppo, A.–M., and Repo, H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med., 85: 289–291, 1988.
25. Torti, F. M., Dieckmann, B., Beutler, B., Cerami, A., and Ringold, G. M. A macrophage factor inhibits adipocyte gene expression: an in–vitro model of cachexia. Science (Wash. DC), 229: 867–869, 1985.
26. Moser, R., Schleiffenbaum, B., Groscurth, P., and Fehr, J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J. Clin. Invest., 83: 444–455, 1989.